Fjarde Ap-fonden’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-57,500
| Closed | -$2.59M | – | 571 |
|
|
2021
Q1 | $2.59M | Buy |
57,500
+3,400
| +6% | +$153K | 0.02% | 530 |
|
|
2020
Q4 | $3.06M | Buy |
54,100
+1,100
| +2% | +$62.2K | 0.03% | 502 |
|
|
2020
Q3 | $2.52M | Buy |
53,000
+5,600
| +12% | +$266K | 0.03% | 513 |
|
|
2020
Q2 | $2.8M | Sell |
47,400
-1,900
| -4% | -$112K | 0.04% | 471 |
|
|
2020
Q1 | $2.33M | Buy |
49,300
+500
| +1% | +$23.6K | 0.04% | 451 |
|
|
2019
Q4 | $2.95M | Buy |
48,800
+16,900
| +53% | +$1.02M | 0.04% | 488 |
|
|
2019
Q3 | $1.91M | Sell |
31,900
-500
| -2% | -$30K | 0.02% | 539 |
|
|
2019
Q2 | $2.08M | Buy |
+32,400
| New | +$2.08M | 0.03% | 528 |
|
|
2016
Q4 | – | Sell |
-219
| Closed | -$8K | – | 629 |
|
|
2016
Q3 | $8K | Sell |
219
-35,910
| -99% | -$1.31M | ﹤0.01% | 613 |
|
|
2016
Q2 | $841K | Sell |
36,129
-977
| -3% | -$22.7K | 0.02% | 609 |
|
|
2016
Q1 | $1.5M | Buy |
37,106
+3,241
| +10% | +$131K | 0.03% | 553 |
|
|
2015
Q4 | $2.1M | Buy |
33,865
+1,318
| +4% | +$81.6K | 0.06% | 414 |
|
|
2015
Q3 | $1.32M | Hold |
32,547
| – | – | 0.04% | 542 |
|
|
2015
Q2 | $1.87M | Sell |
32,547
-2,653
| -8% | -$153K | 0.05% | 501 |
|
|
2015
Q1 | $2.24M | Buy |
+35,200
| New | +$2.24M | 0.05% | 451 |
|